0001209191-15-067054.txt : 20150820 0001209191-15-067054.hdr.sgml : 20150820 20150820130351 ACCESSION NUMBER: 0001209191-15-067054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150818 FILED AS OF DATE: 20150820 DATE AS OF CHANGE: 20150820 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000949858 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 954343413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19820 NORTH CREEK PARKWAY STREET 2: SUITE 201 CITY: BOTHELL STATE: WA ZIP: 98011 BUSINESS PHONE: 425-686-1500 MAIL ADDRESS: STREET 1: 19820 NORTH CREEK PARKWAY STREET 2: SUITE 201 CITY: BOTHELL STATE: WA ZIP: 98011 FORMER COMPANY: FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bencich John CENTRAL INDEX KEY: 0001477056 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 033-80623 FILM NUMBER: 151065900 MAIL ADDRESS: STREET 1: 2401 FOURTH AVENUE, SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-18 0 0000949858 ONCOGENEX PHARMACEUTICALS, INC. OGXI 0001477056 Bencich John 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 0 1 0 0 CFO Common Stock 2015-08-18 4 M 0 5000 0.00 A 5000 D Common Stock 2015-08-18 4 S 0 1427 2.76 D 3573 D Restricted Stock Unit (RSU) 2015-08-18 4 M 0 5000 0.00 D Common Stock 5000 15000 D Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Represents shares of common stock that have been sold by the issuer to satisfy the tax liability in connection with the settlement of RSUs. Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock at settlement. Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of: (i) each anniversary of August 12, 2014 and (ii) the first day thereafter during which the issuer's trading window is open. The RSUs expire 30 days from the date they vest. Sandra Thomson as attorney-in-fact for John Bencich 2015-08-20